ZA200001010B - Microdisperse drug delivery systems. - Google Patents

Microdisperse drug delivery systems.

Info

Publication number: ZA200001010B
Authority: ZA; South Africa
Prior art keywords: microdisperse; drug delivery; delivery systems; systems; drug
Prior art date: 1998-07-14

Application number

ZA200001010A

Inventor

Siva Narayan Tallavajhala

Original Assignee

Em Ind Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-14

Filing date

2000-02-29

Publication date

2000-10-16

2000-02-29 Application filed by Em Ind Inc filed Critical Em Ind Inc

2000-10-16 Publication of ZA200001010B publication Critical patent/ZA200001010B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Dispersion Chemistry (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA200001010A 1998-07-14 2000-02-29 Microdisperse drug delivery systems. ZA200001010B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US9276798P	1998-07-14	1998-07-14

Publications (1)

Publication Number	Publication Date
ZA200001010B true ZA200001010B (en)	2000-10-16

Family

ID=22235064

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200001010A ZA200001010B (en)	1998-07-14	2000-02-29	Microdisperse drug delivery systems.

Country Status (8)

Country	Link
EP (1)	EP1015046A2 (en)
JP (1)	JP2002520377A (en)
CN (1)	CN1273526A (en)
AU (1)	AU4989299A (en)
CA (1)	CA2302735A1 (en)
DE (1)	DE1015046T1 (en)
WO (1)	WO2000003753A2 (en)
ZA (1)	ZA200001010B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ512599A (en)	1998-12-30	2003-10-31	Dexcel Ltd	Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5
US20030236236A1 (en) *	1999-06-30	2003-12-25	Feng-Jing Chen	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
AU2002239282A1 (en)	2000-11-28	2002-06-11	Transform Pharmaceuticals, Inc.	Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
US20030068375A1 (en)	2001-08-06	2003-04-10	Curtis Wright	Pharmaceutical formulation containing gelling agent
US20040092428A1 (en) *	2001-11-27	2004-05-13	Hongming Chen	Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
FR2833842B1 (en) *	2001-12-21	2004-02-13	Aventis Pharma Sa	PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
EP1498122A1 (en) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Semi-solid systems containing azetidine derivatives
EP1498143A1 (en) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
BRPI0418427A (en) *	2004-01-30	2007-06-12	Pfizer Italia Srl	semi-solid matrix pharmaceutical formulations
US7345093B2 (en)	2004-04-27	2008-03-18	Formatech, Inc.	Methods of enhancing solubility of compounds
US7659310B2 (en)	2004-04-27	2010-02-09	Formatech, Inc.	Methods of enhancing solubility of agents
FR2873585B1 (en) *	2004-07-27	2006-11-17	Aventis Pharma Sa	NEW GALENIC FORMULATIONS OF ACTIVE PRINCIPLES
GB2451811A (en)	2007-08-09	2009-02-18	Ems Sa	Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
TW200922549A (en) *	2007-10-19	2009-06-01	Abbott Gmbh & Amp Co Kg	Solid dispersion product containing N-aryl urea-based compound
US11304960B2 (en)	2009-01-08	2022-04-19	Chandrashekar Giliyar	Steroidal compositions
US10143652B2 (en)	2009-09-23	2018-12-04	Curirx Inc.	Methods for the preparation of liposomes
US8591942B2 (en)	2009-09-23	2013-11-26	Indu JAVERI	Methods for the preparation of liposomes comprising docetaxel
US9034858B2 (en)	2010-11-30	2015-05-19	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20180153904A1 (en)	2010-11-30	2018-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9358241B2 (en)	2010-11-30	2016-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20120148675A1 (en)	2010-12-10	2012-06-14	Basawaraj Chickmath	Testosterone undecanoate compositions
WO2016033556A1 (en)	2014-08-28	2016-03-03	Lipocine Inc.	BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en)	2014-08-28	2016-03-03	Lipocine Inc.	(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016205423A2 (en)	2015-06-15	2016-12-22	Lipocine Inc.	Composition and method for oral delivery of androgen prodrugs
EP3544614A4 (en)	2016-11-28	2020-08-05	Lipocine Inc.	ORAL TESTOSTERONE UNDECANOATE THERAPY
CA3107214A1 (en)	2018-07-20	2020-01-23	Lipocine Inc.	Liver disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5565188A (en) *	1995-02-24	1996-10-15	Nanosystems L.L.C.	Polyalkylene block copolymers as surface modifiers for nanoparticles

1999
- 1999-07-14 CN CN99801129A patent/CN1273526A/en active Pending
- 1999-07-14 DE DE1015046T patent/DE1015046T1/en active Pending
- 1999-07-14 WO PCT/US1999/015781 patent/WO2000003753A2/en not_active Application Discontinuation
- 1999-07-14 CA CA002302735A patent/CA2302735A1/en not_active Abandoned
- 1999-07-14 AU AU49892/99A patent/AU4989299A/en not_active Abandoned
- 1999-07-14 JP JP2000559887A patent/JP2002520377A/en active Pending
- 1999-07-14 EP EP99933952A patent/EP1015046A2/en not_active Withdrawn
2000
- 2000-02-29 ZA ZA200001010A patent/ZA200001010B/en unknown

Also Published As

Publication number	Publication date
WO2000003753A3 (en)	2000-05-04
CN1273526A (en)	2000-11-15
DE1015046T1 (en)	2001-02-08
CA2302735A1 (en)	2000-01-27
JP2002520377A (en)	2002-07-09
AU4989299A (en)	2000-02-07
EP1015046A2 (en)	2000-07-05
WO2000003753A2 (en)	2000-01-27

Publication	Publication Date	Title
ZA200001010B (en)	2000-10-16	Microdisperse drug delivery systems.
ZA200107123B (en)	2003-02-26	Oral drug delivery system.
EP1080231A4 (en)	2004-01-14	Multimolecular devices, drug delivery systems and single-molecule selection
IL137650A0 (en)	2001-10-31	Drug delivery devices
HUP0300246A3 (en)	2005-09-28	Delivery system
EP1104286A4 (en)	2009-04-15	Composite hydrogel drug delivery systems
AU1618800A (en)	2000-06-13	Microporous drug delivery system
EP1061987A4 (en)	2003-04-09	Drug delivery system
EP1098673A4 (en)	2004-07-21	Agent delivery systems
EP0989878A4 (en)	2000-10-25	Drug delivery system
ZA99283B (en)	1999-12-08	Inhaler for medication.
ZA97976B (en)	1997-08-18	Uniform drug delivery theraphy.
ZA200203707B (en)	2003-10-29	Pharmaceutical combinations.
GB9809933D0 (en)	1998-07-08	Drug delivery device
ZA200000610B (en)	2001-06-11	Micro-osmotic controlled drug delivery systems.
AU2367900A (en)	2000-07-03	Chewable drug delivery system
EP1021137A4 (en)	2000-12-06	Drug delivery system
GB9811691D0 (en)	1998-07-29	Flavour delivery systems
GB2352314B (en)	2003-11-26	Delivery system
GB0011066D0 (en)	2000-06-28	Delivery system
GB0029843D0 (en)	2001-01-24	Drug delivery system
GB9914960D0 (en)	1999-08-25	Delivery system
AU2002210580A1 (en)	2002-04-29	Drug delivery system
ZA974920B (en)	1998-02-25	Drug delivery systems.
GB9600471D0 (en)	1996-03-13	Drug delivery system